Desflurane

Generic name
Desflurane
Brand name
ATC Code
N01AB07

Desflurane

Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Pharmacokinetics in children

The MAC decreases as age progresses.

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

Maintenance anaesthesia
  • Inhalation
    • 1 month up to 18 years
      • Minimale alveolaire concentratie

        • 100 %oxygen: ~7% to 10%
        • Met 60% nitric oxide: ~ 4-7,5 %
        Age MAC met 100% oxygen MAC met 60% nitric oxide and 40% oxygen
        10 weeks 9,4 ± 0,4  
        9 months 10,0 ± 0,7 7,5 ± 0,8
        2 years 9,1 ± 0,6  
        3 years   6,4 ± 0,4
        4 years 8,6 ± 0,6  
        7 years 8,1 ± 0,6  
        25 years 7,3 ± 0,0 4,0 ± 0,3

         

        Inhalation: 5-10% by volume with or without nitrous oxide, in children sometimes for a short time 18% by volume with nitrous oxide and at least 25% oxygen by volume

      • With monitoring of the blood pressure and heart rate

    • 2 weeks up to 4 weeks
      • Minimale alveolaire concentratie

        Age MAC met 100% oxygen
        2 weeks 9,2 ± 0,0

         

      • With monitoring of the blood pressure and heart rate

Renal impaiment in children > 3 months

No information available on dose adjustment in renal impairment.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects in children

In children aged 6 years and under, the risk of side effects such as coughing and laryngeal spasms is elevated. This occurs particularly when the laryngeal mask is removed under deep anaesthesia.

Postoperative agitation has been reported in children that can be expressed as disorientation, tearful behaviour and striking movements.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications in children

For the induction of inhalation anesthesia in children, since coughing, breath-holding, respiratory arrest, laryngospasm and increased secretions often occur.
Due to the limited data available in non-intubated paediatric patients, desflurane is not indicated for the maintenance of anaesthesia in non-intubated children. (SmPC Suprane)

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions in children

Use in children with bronchial hyperresponsiveness:
Desflurane should definitely be used with extra caution in children with asthma or recent upper respiratory tract infections due to the risk of airway narrowing and increased airway resistance.

Maintenance of anaesthesia in children:
Caution should be exercised when using desflurane for maintenance of anaesthesia with a laryngeal mask airway (LMA), particularly in children up to 6 years of age, as there is an increased risk of respiratory complications such as cough and laryngospasm, especially after discontinuation of the laryngeal mask airway under deep anaesthesia.

When children recover after anaesthesia, a brief period of agitation may occur that prevents cooperation.

[SmPC Suprane]

Middle ear operations:
Desflurane, like other volatile anaesthetics, leads to an increase in pressure in the middle ear, especially in children. Monitoring of the pressure in the middle ear is therefore recommended during anaesthesia with desflurane.

[SmPC Desflurane Piramal]

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

ANESTHETICS, GENERAL

This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.

Halogenated hydrocarbons
N01AB06
N01AB08
Barbiturates, plain
N01AF03
Opioid anesthetics
N01AH02
N01AH01
N01AH06
N01AH03
Other general anesthetics
N01AX01
N01AX14
N01AX07
N01AX10

References

  1. Baxter BV, SmPC Suprane (RVG 17364) 25-05-2016, www.geneesmiddeleninformatiebank.nl
  2. Piramal Critical Care B.V, SmPC Desfluraan Piramal 100 % vloeistof voor inhalatiedamp (RVG 131310) 03-08-2023, www.geneesmiddeleninformatiebank.nl

Changes

Therapeutic Drug Monitoring


Overdose